StockNow
Log in
U.S. Markets

HCA Healthcare (HCA) sees Q2 EPS USD 7.62 (exp. 7.47), Revenue 20.23bln (exp. 19.38bln); Lowers FY26 EPS view to USD 28.70-30.50 (prev. 29.10-31.50, exp. 30.19)

StockNow breaking-news AI analysis

HCA beat Q2 estimates but lowered FY26 guidance due to broader sector headwinds like rising operating costs and reimbursement uncertainties, despite favorable long-term demographics.

News detail

Narrows FY26 revenue view to USD 77-79.5bln (prev. 76.5-80bln, exp. 78.58bln). Lowers FY26 adj. EBITDA view to USD 15.4-16.1bln (prev. 15.55-16.45bln).

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYU.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)

Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement